Vysioneer: Funding, Investors & Team (Sep 2026)
Vysioneer is a company specializing in AI for oncology. Our goal is to enhance the understanding of tumor heterogeneity in cancer treatment by utilizing lesion-level data. Through our FDA-cleared AI platform, we assist pharmaceutical companies in uncovering precise tumor characteristics at the lesion level, which in turn reduces risks and expedites clinical trials. Vysioneer is currently utilizing its AI platform to establish the largest database globally for assessing drug effectiveness at the lesion level.
Vysioneer has raised $750k across 1 funding round on record, the most recent an undisclosed round of $750k announced in Jun 2023.
That round is below the $5.7M median round size for Artificial Intelligence companies tracked on FundedIQ over the last two years.
Vysioneer Company Profile and Key Stats
Latest funding round on record: Jun 2023.
Vysioneer Funding Rounds
Vysioneer Founders and Leadership Team
No contact details are on record for this team yet.
Vysioneer Funding Compared to Other Artificial Intelligence Startups
Vysioneer's latest round of $750k is below the median round in Artificial Intelligence. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Vysioneer in Artificial Intelligence and Cambridge
Companies Similar to Vysioneer
Cradlewise is an intelligent baby crib that learns from the baby's sleep patterns, spots the first signs of…
Capacity is an AI-powered helpdesk that automates support for customers and employees. Capacity connects…
AfterQuery is an artificial intelligence research and data platform focused on creating high-quality,…
The future of translation is conversational and Language I/O’s proprietary machine translation optimization…
Greptile is a platform driven by artificial intelligence that evaluates codebases and improves development…
Rhealth is a biotechnology company offering hospitals health management solutions utilizing advanced AI…
Socure is a predictive analytics platform for digital identity verification of consumers. Socure's predictive…
Instinct is an artificial intelligence startup developing AI technology.
Significant gives vehicle-mounted PC vision innovation that distinguishes visual deformities in network…
Cloverleaf AI exists to help you fill your pipeline with high-quality SLED leads. Tell us what you deliver,…
Emerald AI develops software and platforms that manage and coordinate energy use for artificial intelligence…
Vysioneer Funding FAQs
What does Vysioneer do?
Vysioneer is a company specializing in AI for oncology. Our goal is to enhance the understanding of tumor heterogeneity in cancer treatment by utilizing lesion-level data. Through our FDA-cleared AI platform, we assist pharmaceutical companies in uncovering precise tumor characteristics at the lesion level, which in turn reduces risks and expedites clinical trials. Vysioneer is currently utilizing its AI platform to establish the largest database globally for assessing drug effectiveness at the lesion level.
How much funding has Vysioneer raised?
Vysioneer has raised $750k across 1 round on record. The most recent is an undisclosed round of $750k announced in Jun 2023.
When did Vysioneer last raise funding?
Vysioneer's most recent funding round on record is an undisclosed round of $750k, announced in Jun 2023.
Who founded Vysioneer?
FundedIQ lists Jen Tang Lu (Founder) at Vysioneer.
Where is Vysioneer headquartered?
Vysioneer is based in Cambridge, Massachusetts, United States.
How many employees does Vysioneer have?
Vysioneer is in the 11-50 employee band.
How does Vysioneer's funding compare to other Artificial Intelligence startups?
Vysioneer's latest round of $750k is below the $5.7M median round size for Artificial Intelligence companies on FundedIQ across 7,234 tracked companies over the last two years.
About FundedIQ's Vysioneer Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Vysioneer is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.